1. Home
  2. XRAY vs GENB Comparison

XRAY vs GENB Comparison

Compare XRAY & GENB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo DENTSPLY SIRONA Inc.

XRAY

DENTSPLY SIRONA Inc.

N/A

Current Price

$9.31

Market Cap

1.7B

Sector

Health Care

ML Signal

N/A

Logo Generate Biomedicines Inc. Common Stock

GENB

Generate Biomedicines Inc. Common Stock

N/A

Current Price

$12.53

Market Cap

1.7B

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
XRAY
GENB
Founded
1899
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.7B
IPO Year
2009
2026

Fundamental Metrics

Financial Performance
Metric
XRAY
GENB
Price
$9.31
$12.53
Analyst Decision
Hold
Strong Buy
Analyst Count
17
6
Target Price
$11.03
★ $27.00
AVG Volume (30 Days)
★ 4.9M
901.7K
Earning Date
11-05-2026
11-24-2026
Dividend Yield
★ 1.64%
N/A
EPS Growth
★ 33.04
N/A
EPS
★ 0.12
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$0.64
N/A
P/E Ratio
$81.29
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$8.14
$11.00
52 Week High
$14.76
$22.67

Technical Indicators

Market Signals
Indicator
XRAY
GENB
Relative Strength Index (RSI) 47.99 43.75
Support Level $8.32 $11.93
Resistance Level $10.71 $14.29
Average True Range (ATR) 0.51 1.16
MACD 0.02 0.00
Stochastic Oscillator 46.53 21.77

Price Performance

Historical Comparison
XRAY
GENB

About XRAY DENTSPLY SIRONA Inc.

Dentsply Sirona is one of the world's largest manufacturers of dental equipment and supplies. It is a result of a merger of equals in 2016 between Dentsply International (dental consumables and lab products) and Sirona Dental Systems (technologically advanced dental equipment). The firm's wide portfolio consists of dental consumables, lab products, CAD/CAM and imaging technology, medical devices, and specialty products in orthodontics, endodontics, and implantology. It distributes two-thirds of its dental consumables, technology, and equipment through third-party distributors. The remaining portfolio is sold to labs and offices through the firm's salesforce or directly to consumers.

About GENB Generate Biomedicines Inc. Common Stock

Generate Biomedicines Inc is a clinical-stage generative biology company pioneering the AI revolution in biotechnology and drug design and development. The company's single operating segment is engaged in the field of generative biology by using machine learning for drug discovery and development through the programming of novel protein therapeutics. Its product candidates include: GB-0895, GB-4362, and GB-5267. Through the company's Generate Platform, it can generate medicines on demand across multiple therapeutic modalities with unprecedented speed representing a fundamental shift in drug discovery.

Share on Social Networks: